The hypotensive effect of a single daily dose of labetalol: a preliminary study.Int J Clin Pharmacol Ther Toxicol. 1982 Sep; 20(9):438-45.IJ
Abstract
We analyzed the efficacy of a single daily dose of labetalol (300 mg) administered at 9 a.m. in six inpatients suffering from medium-severe hypertension. The study was conducted on 3 consecutive days, during which the patients were on labetalol, placebo, and non-treatment (control) according to a trial design of the Latin square type, balanced for residual effects. The hypotensive effect of labetalol manifests itself between hours 1 and 2 after administration of the drug. The systolic and diastolic blood pressure values always proved lower after labetalol as compared to placebo and non-treatment (control) as well as to the average of the latter two values (placebo + control) divided by 2. No side effects were detected.
MeSH
Pub Type(s)
Clinical Trial
Controlled Clinical Trial
Journal Article
Language
eng
PubMed ID
6754634
Citation
Rossi, A, et al. "The Hypotensive Effect of a Single Daily Dose of Labetalol: a Preliminary Study." International Journal of Clinical Pharmacology, Therapy, and Toxicology, vol. 20, no. 9, 1982, pp. 438-45.
Rossi A, Ziacchi V, Lomanto B. The hypotensive effect of a single daily dose of labetalol: a preliminary study. Int J Clin Pharmacol Ther Toxicol. 1982;20(9):438-45.
Rossi, A., Ziacchi, V., & Lomanto, B. (1982). The hypotensive effect of a single daily dose of labetalol: a preliminary study. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 20(9), 438-45.
Rossi A, Ziacchi V, Lomanto B. The Hypotensive Effect of a Single Daily Dose of Labetalol: a Preliminary Study. Int J Clin Pharmacol Ther Toxicol. 1982;20(9):438-45. PubMed PMID: 6754634.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - The hypotensive effect of a single daily dose of labetalol: a preliminary study.
AU - Rossi,A,
AU - Ziacchi,V,
AU - Lomanto,B,
PY - 1982/9/1/pubmed
PY - 1982/9/1/medline
PY - 1982/9/1/entrez
SP - 438
EP - 45
JF - International journal of clinical pharmacology, therapy, and toxicology
JO - Int J Clin Pharmacol Ther Toxicol
VL - 20
IS - 9
N2 - We analyzed the efficacy of a single daily dose of labetalol (300 mg) administered at 9 a.m. in six inpatients suffering from medium-severe hypertension. The study was conducted on 3 consecutive days, during which the patients were on labetalol, placebo, and non-treatment (control) according to a trial design of the Latin square type, balanced for residual effects. The hypotensive effect of labetalol manifests itself between hours 1 and 2 after administration of the drug. The systolic and diastolic blood pressure values always proved lower after labetalol as compared to placebo and non-treatment (control) as well as to the average of the latter two values (placebo + control) divided by 2. No side effects were detected.
SN - 0174-4879
UR - https://www.unboundmedicine.com/medline/citation/6754634/The_hypotensive_effect_of_a_single_daily_dose_of_labetalol:_a_preliminary_study_
DB - PRIME
DP - Unbound Medicine
ER -